Hemafuse is designed to salvage and recycle whole blood from cases of internal bleeding.
The device can be used in both emergencies and scheduled procedures to recover blood from where it pools inside of a patient, into a blood bag, where it is immediately available to be re-transfused back to that same patient.
Hemafuse was created for patients suffering from internal bleeding resulting from trauma, ruptured ectopic pregnancies, or for use in planned surgeries. Hemafuse can be used in cases where there is no donor blood available, and even as the preferred option over donor blood.
When compared to autotransfusion, the use of donor blood comes with a higher risk of disease transfer, increased length of stay, readmissions, and other complications.
Hemafuse is now used in 10 different hospitals across Kenya. Last month, Hemafuse received an endorsement from The First Lady, Margaret Kenyatta at the launch of the Nairobi Beyond Zero Medical Safari held at Uhuru Park Nairobi on January, 25 2020.
During the event, Dr. Elizabeth Wala, Programme Director for Health Systems Strengthening at Amref Health Africa in Kenya, announced that the Kenya Pharmacy and Poison Board have approved Hemafuse.
“Blood is a matter of life and death, the impact of this device is saving lives that could have been lost due to lack of blood. Achieving [Universal Health Coverage] requires innovations for essential medicines and health technologies that save lives,” she added.
Dr. Gerald Osei-Owusu, a Medical Officer at Tema General, has used Hemafuse in several different surgeries. After experiencing Hemafuse first hand, he says the device cuts down on cost, the time it takes to save the patient, and reduces their recovery time.
Using Hemafuse to recycle a patient’s own blood saves the donor blood that is available for other patients who are not candidates for autotransfusion.
Autotransfusion reduces the risk of infection and disease transmission because using a patient’s own blood is safer than someone else’s.
Hemafuse is now available at hospitals in Kenya and Ghana, and will be coming to hospitals across Africa